Floatz logo

Red Blood Cells

Hereditary Persistence Of Fetal Hemoglobin

Hospital Clinic of BarcelonaCell therapyN/AActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

10 Active assets in the Hereditary Persistence Of Fetal Hemoglobin cohort.

Asset / SponsorPhaseRating
Hydroxyurea
National Institute of Blood and Marrow Transplant (NIBMT), Pakistan
Phase 2CCC
Melphalan
Masonic Cancer Center, University of Minnesota
Phase 2CCC
Anti-Human T-Lymphocyte Immunoglobulin, Rabbit
Masonic Cancer Center, University of Minnesota
Phase 2CCC
Busulfanum
Masonic Cancer Center, University of Minnesota
Phase 2CCC
Rituximab
Masonic Cancer Center, University of Minnesota
Phase 2CCC

View all 10 →

Same molecule, other indications

Red Blood Cells is also rated in:

beta-thalassemia majorDormant
B
Indicative · Phase 3
62 / 100
View asset →
relapsing-remitting multiple sclerosisActive
CC
Indicative · Phase 1
46 / 100
View asset →
retinopathy of prematurityActive
D
Indicative · N/A
30 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →